# A Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Effects of Three Doses of the Dietary Supplement oréVida™ on Alertness, Attention and Concentration in Healthy Men and Women

> **NCT01143194** · PHASE1 · COMPLETED · sponsor: **dsm-firmenich Switzerland AG** · enrollment: 44 (actual)

## Conditions studied

- Attention
- Memory
- Alertness

## Interventions

- **DIETARY_SUPPLEMENT:** oréVida™
- **DIETARY_SUPPLEMENT:** oréVida™
- **DIETARY_SUPPLEMENT:** oréVida™
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01143194
- **Lead sponsor:** dsm-firmenich Switzerland AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2011-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01143194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01143194, "A Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Effects of Three Doses of the Dietary Supplement oréVida™ on Alertness, Attention and Concentration in Healthy Men and Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01143194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*